Clinical Trial

Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver

Name: Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty Liver — clinical trial record (NCT07637006)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LJF

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blinded, placebo-controlled clinical trial aimed at evaluating the efficacy and safety of Linzhi Jianghuang Fufang Huoxue Anshen Capsule (LJF) for non-alcoholic fatty liver.

Trial Details

NCT Number	NCT07637006
Lead Sponsor	Hong Kong Baptist University
Conditions	Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Enrollment	180 participants
Start Date	2026-09
Primary Completion	2028-07 (estimated)
Study Completion	2029-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-09